Growth Metrics

Trinity Biotech (TRIB) Total Current Liabilities (2016 - 2025)

Trinity Biotech's Total Current Liabilities history spans 17 years, with the latest figure at $141.2 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 339.97% to $141.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $141.2 million, a 339.97% increase, with the full-year FY2025 number at $141.2 million, up 339.97% from a year prior.
  • Total Current Liabilities hit $141.2 million in Q4 2025 for Trinity Biotech, up from $31.5 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for TRIB hit a ceiling of $141.2 million in Q4 2025 and a floor of $12.7 million in Q3 2023.
  • Historically, Total Current Liabilities has averaged $41.3 million across 5 years, with a median of $24.3 million in 2024.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 364.27% in 2021 and later crashed 86.86% in 2022.
  • Tracing TRIB's Total Current Liabilities over 5 years: stood at $100.5 million in 2021, then crashed by 82.75% to $17.3 million in 2022, then decreased by 13.29% to $15.0 million in 2023, then skyrocketed by 113.47% to $32.1 million in 2024, then surged by 339.97% to $141.2 million in 2025.
  • Business Quant data shows Total Current Liabilities for TRIB at $141.2 million in Q4 2025, $31.5 million in Q2 2025, and $32.1 million in Q4 2024.